Epoetin beta
| Data klinis | |
|---|---|
| Pengucapan | /ɛˈpoʊ.ɪtɪn/ |
| Nama dagang | Mircera, Recormon, dll[1] |
| AHFS/Drugs.com | International Drug Names |
| License data | |
| Kategori kehamilan | |
| Rute pemberian | Intravena, subkutan |
| Kode ATC | |
| Status hukum | |
| Status hukum | |
| Pengenal | |
| Nomor CAS | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| | |
Epoetin beta (INN) adalah bentuk eritropoietin sintetis rekombinan,[4] suatu protein yang mendorong produksi sel darah merah. Obat ini adalah agen stimulan eritropoiesis (ESA) yang digunakan untuk mengobati anemia, yang umumnya terkait dengan gagal ginjal kronis dan kemoterapi kanker. Obat ini tercantum dalam Daftar Obat Esensial Organisasi Kesehatan Dunia.[5]
Sejarah
Epoetin beta adalah bentuk rekombinan eritropoietin manusia yang diproduksi di sel ovarium hamster Cina. Ia memiliki urutan protein yang sama dengan eritropoietin manusia alami, yang terdiri dari 165 asam amino dengan berat molekul sekitar 30 KDa.[6]
Referensi
- ^ Centers for Medicare and Medicaid Services: Erythrocyte Stimulating Agents Diarsipkan 2017-06-07 di Wayback Machine.. Retrieved 15 February 2017.
- ^ a b Australian product information Diarsipkan 2023-01-09 di Wayback Machine. guildlink.com.au
- ^ "NeoRecormon EPAR". European Medicines Agency (EMA). 17 September 2018. Diarsipkan dari versi aslinya tanggal 9 January 2023. Diakses tanggal 9 January 2023.
- ^ Dunn CJ, Markham A (February 1996). "Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure". Drugs. 51 (2): 299–318. doi:10.2165/00003495-199651020-00008. PMID 8808169. S2CID 46985336.
- ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
- ^ Medsafe: Neorecormon Datasheet Diarsipkan 2020-08-30 di Wayback Machine.
Bacaan lebih lanjut
- Jenkins JK (2007-06-26). "Erythropoiesis-Stimulating Agents (ESA)". U.S. Food and Drug Administration (FDA). Diarsipkan dari asli tanggal 5 March 2010.
Pranala luar
- "Epoetin beta". Drug Information Portal. U.S. National Library of Medicine. Diarsipkan dari asli tanggal April 7, 2020.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.